Anixa Biosciences (ANIX) Cash from Investing Activities (2010 - 2026)
Anixa Biosciences (ANIX) reported Cash from Investing Activities of -$245,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$833,000 a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Anixa Biosciences' Cash from Investing Activities came in at $1.92 million, down 62.2% year-over-year; for FY2025 (ended Oct 31, 2025), it was $4.87 million, up 13.8% from FY2024.
- By fiscal year, Cash from Investing Activities came in at $4.28 million in FY2024, -$5.6 million in FY2023, -$10.73 million in FY2022 and -$3.92 million in FY2021.
- Five-year quarterly Cash from Investing Activities spans a low of -$9.92 million in fiscal Q4 2022 and a high of $2.81 million in fiscal Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Anixa Biosciences | 102.02 Mn | 100.75 Mn | - | -245,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -245,000.00 |
| Oct 31, 2025 | 654,000.00 |
| Jul 31, 2025 | -833,000.00 |
| Apr 30, 2025 | 2.34 Mn |
| Jan 31, 2025 | 2.70 Mn |
| Oct 31, 2024 | 867,000.00 |
| Jul 31, 2024 | 2.72 Mn |
| Apr 30, 2024 | 556,000.00 |
| Jan 31, 2024 | 129,000.00 |
| Oct 31, 2023 | -593,000.00 |
| Jul 31, 2023 | -980,000.00 |
| Apr 30, 2023 | -3.44 Mn |
| Jan 31, 2023 | -585,000.00 |
| Oct 31, 2022 | -9.92 Mn |
| Jul 31, 2022 | -2.91 Mn |
| Apr 30, 2022 | 250,000.00 |
| Jan 31, 2022 | 1.85 Mn |
| Oct 31, 2021 | 2.81 Mn |
| Jul 31, 2021 | 1.00 Mn |
| Apr 30, 2021 | -8.40 Mn |
API Access
Anixa Biosciences Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();